Holen Sie sich die Stockscreener-App
53.70
1.86%
-1.02
Handel nachbörslich:
53.70
Finanzdaten der Crinetics Pharmaceuticals Inc-Aktie (CRNX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
0.64
|
- | 0.346 | 0.988 | 2.679 |
Operating Expenses
|
18.37%
74.17
|
62.66 | 59.32 | 53.98 | 50.66 |
| Benefits Costs and Expenses |
100.00%
-
|
218.54 | - | - | - |
| Costs And Expenses |
35.89%
74.17
|
54.58 | 59.32 | 53.98 | 50.66 |
| Depreciation and Amortization |
80.92%
0.474
|
0.262 | 0.273 | 0.28 | 0.283 |
| Operating Income/Loss |
17.35%
-73.53
|
-62.66 | -58.98 | -52.99 | -47.98 |
| Nonoperating Income/Loss |
4.54%
7.069
|
6.762 | 2.516 | 2.016 | 1.983 |
| Income/Loss From Continuing Operations Before Tax |
100.29%
0.64
|
-218.54 | 0.346 | 0.988 | 2.679 |
| Income/Loss From Continuing Operations After Tax |
11.37%
-66.93
|
-60.10 | -57.46 | -50.98 | -45.99 |
|
Net Income/Loss
|
11.37%
-66.93
|
-60.10 | -57.46 | -50.98 | -45.99 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
2,256%
72.29
|
3.068 | 56.81 | 54.27 | 53.91 |
| Diluted Average Shares |
2,256%
72.29
|
3.068 | 56.81 | 54.27 | 53.91 |
| Basic Earnings Per Share |
5.68%
-0.93
|
-0.88 | -1.01 | -0.94 | -0.85 |
| Diluted Earnings Per Share |
5.68%
-0.93
|
-0.88 | -1.01 | -0.94 | -0.85 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):